Make informed decisions with in-depth insights
The Equity Research team is working quickly and diligently to publish timely, value-added reports addressing the coronavirus pandemic and its possible effects on public policy, the overall equity markets and our company coverage universe. For more information, please contact your financial advisor.
Raymond James Equity Research employs more than 60 research analysts dedicated to providing insights and context that help investors connect the dots in key industries and across national borders, and make informed investment decisions. They cover over 1,100 companies in nine highly focused industries – consumer, energy, financial services, healthcare, industrial, mining and natural resources, real estate, technology and communications, and transportation – and collaborate to produce detailed supply chain surveys, reports and industry updates.
Please see below for brief overviews of some of our recent in-depth equity research reports. The full reports are available to clients via their financial advisor, institutional salesperson or other Raymond James representative. Institutional clients can access our equity research by logging in below. If you would like to learn more about becoming a client of Raymond James, please contact us. For all relevant equity research disclosure, visit the Disclosures and Definitions page.
Focusing on the S in ESG
Our report sheds light on social factors under the ESG umbrella that affect the retail industry and our coverage universe. We explore each company's relationship with employees, customers, and communities through workers’ wages, benefits, the CEO pay ratio, and employee satisfaction.
Clean Tech Primer 2021: Climate Mitigation, Adaptation, and Investing
Clean tech as an investment theme is a multi-decade, multi-pronged growth story situated, in varying degrees, in the energy, technology, and industrial sectors. This growth story is unfolding in the context of how the modern economy is addressing climate change via the twin responses, both insufficient without the other, of mitigation and adaptation.
Covid Vaccines Timelines: A Detailed Report
We summarize timelines for Moderna, Pfizer/BioNTech, and J&J's late-stage COVID-19 vaccines based on our proprietary trial models, company-reported enrollment data, and published trial protocols.
RX Trends Continue Sisyphean Ascent to Pre-COVID Levels
While U.S. pharmaceutical market prescription levels since mid-March continue to show y/y declines when looking at weekly metrics, overall volume levels appear to have bottomed and continue to show relative resiliency of underlying prescription demand in the wake of COVID-19 mitigation efforts. We reiterate the belief that the overall pharmaceutical demand curve will show little lasting impact from recent disruption and the sector itself is uniquely positioned to return to normalcy via a "V bottom" in prescription trends.
3Q20 ESG Update: Decoding the “S” in ESG
In this report, we highlight the “S” in ESG, as this social element is likely the hardest for many investors to tie to financial materiality, and has been brought forth into the limelight by the pandemic/shutdown and economic fallout. Ultimately, we believe that as the economy inexorably moves to being more labor/creative-intensive over time, companies that have the ability to attract and retain the most talented/motivated employees have a clear advantage.
Insights Into How This Crisis Alters Business Trends Across Every Sector of the Economy
In this report, we highlight a number of changes in macro trends related to the COVID crisis and shutdowns that we believe will be long-lasting. We have compiled insights from our research analysts to examine the reversal of prior long-term trends, the acceleration of e-commerce, the need for meaningful investment in certain sectors, and ongoing ESG themes.
Precious Metals: Risk, Reward, and Valuation Analysis
Gold is generally viewed as its own investment class given its unique characteristics. Given increased investor interest in gaining exposure to gold through equities, this report outlines how the royalty/streaming model works, the risks and rewards of the model, and looks at relative valuation of the royalty/streamers to give investors a better understanding of how these companies can be used to achieve gold exposure in a portfolio.
Covid Temporarily Hitting the Pause Button on Canadian Property Fundamentals
Key potential near-term positive catalysts to keep in mind for the Canadian REIT sector include: positive vaccine developments; improving rent collection and deferral repayment trends; increasing transactional activity in the direct property market that validates estimated NAVs; cap rate compression in certain property sectors; and greater clarity surrounding regulatory risks.
Survey on Traveling in a Covid World
We conducted a survey of U.S. consumers at the end of August to gauge their thoughts on how they expect to change their travel plans due to COVID-19 and expectations for when they will return to more normal travel patterns. This industry report examines our findings and their potential impact on lodging, airlines, and other travel companies.
Security Software, Living in a Golden Age
We believe the cybersecurity software industry is in the midst of a “Golden Age” as the combination of durable growth drivers and low cost of capital have resulted in broad-based outperformance for equity holders, and we believe this trend should continue.
Quantifying the New Normal for Aviation: Who is Most at Risk for a Post-Covid and Flygskam-Influenced World?
Due to lingering health-related fears as well as the more structural trend of avoiding flying due to climate/ESG considerations, it is a good bet that passenger aviation will not return to pre-COVID levels until 2023 at the earliest. Our report provides some perspective on routes that are susceptible to substitution with non-aviation options, and the airlines that are the most vulnerable to such substitution.
Election Symposium Wrap; A Preview of the Post-Election DC Agenda
More fiscal relief, tax uncertainty, continued U.S.-China trade tensions, anti-trust/deal approval security, and ongoing health care debates were all discussed as part of a recent Raymond James Election Symposium.
Log in to Equity Research
Institutional clients can find find recommended lists, market commentaries, equity research, and company information when you log in to your account. If you are already a client but do not have a log-in, or if you do have a log-in but would like to gain access to the equity research of an additional region, please contact your institutional salesperson.
Interested in becoming a client of Raymond James? Please contact firstname.lastname@example.org and a member of the institutional sales department will be in touch to assist you.